Page 10 of 10
Organisation
Study Identifier
(Website)
European Medicines Agency
2019-003981-421
(www.clinicaltrialsregister.eu)
United States National Institutes of Health (NIH)
NCT044283332
(www.clinicaltrials.gov)
The scientific summaries include more details about the requirements for study enrolment,
the study visit schedule, results from other endpoints, and more detailed information about
adverse events.
Your doctor can help you understand more about this study and the results.
You should not make changes to your care based on the results of this or any
single study.
We would like to thank the participants who contributed to this study. The results of
this study will help answer scientific questions about treating participants with head and
neck cancer.
The content for this document was finalised by GSK on 08 September 2022. The information
in this summary does not include additional information available after this date.
1https://www.clinicaltrialsregister.eu/ctr-search/search?query=2019-003981-42
2https://clinicaltrials.gov/ct2/show/NCT04428333